Core and Group Health

A House Committee approved the Biosecure Act to end U.S. contracting with Chinese firms deemed a threat to national security, but filling the void left by Chinese companies may be a challenge to U.S. drug development.

Incorporating value-based primary care models into your portfolio isn't just about expanding your offerings; it's about solidifying your role as a trusted advisor and helping your clients build innovative benefits packages that reflect their businesses.

Giving women employees the resources to manage everyday health can go a long way toward preventing the onset of these conditions.

There is a 19 percentage point gap between employers' perceptions of employee satisfaction with their benefits and actual lived experiences, which has widened since 2021.

In the wake of the May 8 cyberattack on Ascension, which operates 140 hospitals in 19 states, two class-action lawsuits have been filed, alleging that the company failed to safeguard protected health information.

Ozempic, Trulicity and Mounjaro were first approved to treat diabetes, however, in the last three years, the FDA has approved rebranded versions of Mounjaro and Ozempic for weight loss, leading demand – and prices – to skyrocket.

After three years, only a third of 2,000 U.S. hospitals reviewed were in compliance with the Hospital Price Transparency Rule of 2021, says a new PRA report, which puts some of the blame on feds for not enforcing the rule.

At a Senate Judiciary Committee hearing, Senators accused drugmakers of gaming the system by filing 100+ patents for any given drug, while trade group PhRMA said the system advances "the development of new medicines."